These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33260)

  • 21. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of gonadal steroids on dopamine metabolism in mesolimbic and nigro-striatal pathways of male rat brain.
    Alderson LM; Baum MJ
    Brain Res; 1981 Aug; 218(1-2):189-206. PubMed ID: 7272735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions.
    Chrapusta SJ; Karoum F; Egan MF; Wyatt RJ
    Eur J Pharmacol; 1992 Nov; 222(1):129-35. PubMed ID: 1468488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
    Quirion R; Chiueh CC; Everist HD; Pert A
    Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F; Chrapusta SJ; Egan MF
    J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The genotypic correlations of the expression of anxiety and dopamine metabolism in the mouse brain].
    Popova NK; Avgustinovich DF; Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(5):904-10. PubMed ID: 9054142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of mesencephalic lesions on tyramine and dopamine in the caudate nucleus of the rat.
    Juorio AV; Jones RS
    J Neurochem; 1981 Jun; 36(6):1898-903. PubMed ID: 7248031
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging the dopamine uptake site with ex vivo [18F]GBR 13119 binding autoradiography in rat brain.
    Ciliax BJ; Kilbourn MR; Haka MS; Penney JB
    J Neurochem; 1990 Aug; 55(2):619-23. PubMed ID: 2115074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H; Carlsson A
    J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
    Waldmeier PC; Kam R; Stöcklin K
    Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolism of dopamine in the substantia nigra after antidromic activation.
    Korf J; Zieleman M; Westerink BH
    Brain Res; 1977 Jan; 120(1):184-7. PubMed ID: 832118
    [No Abstract]   [Full Text] [Related]  

  • 34. Lateralization of striatal dopamine (D2) receptors in normal rats.
    Schneider LH; Murphy RB; Coons EE
    Neurosci Lett; 1982 Dec; 33(3):281-4. PubMed ID: 7162690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
    Antkiewicz-Michaluk L; Michaluk J; Mokrosz M; Romanska I; Lorenc-Koci E; Ohta S; Vetulani J
    J Neurochem; 2001 Jul; 78(1):100-8. PubMed ID: 11432977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of brain neurotransmitter receptors in aged rats.
    Govoni S; Memo M; Saiani L; Spano PF; Trabucchi M
    Mech Ageing Dev; 1980 Jan; 12(1):39-46. PubMed ID: 6243729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of systemically administered caerulein on dopamine metabolism in rat brain.
    Matsumoto T; Nakahara T; Uchimura H; Hirano M; Yokoo H; Nakamura K; Oomagari K
    Brain Res; 1984 Dec; 324(1):195-9. PubMed ID: 6518389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat.
    Wiesel FA; Sedvall G
    Eur J Pharmacol; 1975 Feb; 30(2):364-7. PubMed ID: 236193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.